Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | KULBINDER SINGH | 1 | ₹6,624 |
| 2 | Schedule 2 | AMAR MEDICO | 1 | ₹6,648 |
| 3 | Schedule 4 | AMAR MEDICO | 5 | ₹6,000 |
| 4 | Schedule 5 | AAP PHARMA | 7 | ₹7,860 |
| 5 | Schedule 6 | KULBINDER SINGH | 6 | ₹4,125 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Jul 2023, 10:00 amClosed
Drug and Medicine
4958021
GEM/2023/B/3624008
Two Packet Bid
Tab Topiramate 50mg,Bupropion HCL 150 mg SR Tab,Buspirone Hcl 10 mg Tab.,Tab Clomipramine Hcl 25 mg
30 days
Jammu And Kashmir; Srinagar
Item wise evaluation
BOQ
5 documents required · 5 mandatory
1 yrs
60%
Exempted
8 Jul 2023
27 Jun 2023
8 Jul 2023
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Tab Topiramate 50mg | 7,200 | No | SRINAGAR | 30 |
| 2 | Bupropion HCL 150 mg SR Tab | 1,200 | No | SRINAGAR | 30 |
| 3 | Buspirone Hcl 10 mg Tab. | 1,800 | No | SRINAGAR | 30 |
| 4 | Tab Clomipramine Hcl 25 mg | 3,000 | No | SRINAGAR | 30 |
| 5 | Fluvoxamine 50 mg Cap | 3,000 | No | SRINAGAR | 30 |
| 6 | Mirtazapine 15 mg Tab | 3,300 | No | SRINAGAR | 30 |
| 7 | Tab Aripiprazole 10 mg | 4,200 | No | SRINAGAR | 30 |
| 8 | Tab Amisulpride 200mg | 600 | No | SRINAGAR | 30 |
| 9 | Tab Quetiapine 100 mg | 6,000 | No | SRINAGAR | 30 |
| 10 | Inj Risperidone Prolonged elease Suspension 25 mg | 12 | Pfs Vial | SRINAGAR | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4958021.pdf
GEM_BID
bbqr-re-28-cfa_2023-06-27-20-59-31_678762e60e41a5f302ee4a5136514fb5.pdf
BOQ
boq-csv_2023-06-27-20-59-31_af3d387a6f11f20932b6d15417ab9c8b.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .